Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Macarena Simón-Talero , Davide Roccarina , Javier Martínez , Katharina Lampichler , Anna Baiges , Gavin Low , Elba Llop , Michael Praktiknjo , Martin H Maurer , Alexander Zipprich , Michela Triolo , Guillaume Vangrinsven , Rita Garcia-Martinez , Annette Dam , Avik Majumdar , Carmen Picón , Daniel Toth , Anna Darnell , Juan G Abraldes , Marta Lopez , Guido Kukuk , Aleksander Krag , Rafael Bañares , Wim Laleman , Vincenzo La Mura , Cristina Ripoll , Annalisa Berzigotti , Jonel Trebicka , Jose Luis Calleja , Puneeta Tandon , Virginia Hernandez-Gea , Thomas Reiberger , Agustín Albillos , Emmanuel A Tsochatzis , Salvador Augustin , Joan Genescà , Sergi Quiroga , Dominic Yu , Mattias Mandorfer , Juan Carlos Garcia-Pagan , Claudia Berbel , Jose Ferrusquia , Michel Ble , Mari Angeles Garcia-Criado , Ernest Belmonte , Michael Ney , Cristina Margini , Stefania Casu , Giuseppe Murgia , Christiane Ludwig , Martin Rönsch , Dietrich Stoevesandt , Laura Carrion , Enrique Ramón Botella Gastroenterology（2018）
摘要
In a retrospective analysis of almost 2000 patients, we found 60% to have SPSSs; prevalence increases with deterioration of liver function. SPSSs increase risk for HE and chronic course. In patients with preserved liver function, SPSSs increase risk for complications and death. ClincialTrials.gov no: NCT02692430.
更多 查看译文
关键词
Collateral Vessels, Portal Hypertension, Advanced Chronic Liver Disease, Portal Pressure
AI 理解论文
溯源树
样例
